In vivo study shows that the size of subcutaneously injected tumours were increased in the wild‐type Zbed3 group as compared with the control group, but the effect was largely inhibited by transfection of the Zbed3 mutant (Figure 6B and C). The gene discussed is ZBED3; the disease is neoplasm.